Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DJAW98
|
|||
| Drug Name |
JointStem
|
|||
| Drug Type |
Cell therapy
|
|||
| Indication | Knee osteoarthritis [ICD-11: FA01; ICD-10: M15-M19, M47; ICD-9: 715] | Phase 2/3 | [1] | |
| Company |
Nature Cell
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04368806) A 48-Weeks, Phase 2b/3a, Double-Blind, Randomized, Placebo Controlled, Multi-center, Superiority Study to Evaluate the Efficacy and Safety of JointStem, Autologous Adipose Tissue Derived Mesenchymal Stem Cells in Patients Diagnosed as Knee Osteoarthritis. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.